SARS-antibody-80R-(IgG) |
|||
| E24CHA001 | EnoGene | Human-,-Human-IgG1. | EUR 276.5 |
|
Description: Human, Human IgG1. |
|||
Human IgG antibody Laboratories manufactures the strand specific sars pcr reagents distributed by Genprice. The Strand Specific Sars Pcr reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact SARS Pcr. Other Strand products are available in stock. Specificity: Strand Category: Specific Group: Sars Pcr
SARS CoV-2 RT PCR kit |
||
| Bioingentech | 50T | EUR 1155.6 |
True Blue |
||
| MedKoo Biosciences | 5.0mg | EUR 595 |
True Blue |
||
| TargetMol Chemicals | 10mg | Ask for price |
|
Description: True Blue |
||
True Blue |
||
| TargetMol Chemicals | 1g | Ask for price |
|
Description: True Blue |
||
True Blue |
||
| TargetMol Chemicals | 1mg | Ask for price |
|
Description: True Blue |
||
True Blue |
||
| TargetMol Chemicals | 50mg | Ask for price |
|
Description: True Blue |
||
True Blue |
||
| TargetMol Chemicals | 5mg | Ask for price |
|
Description: True Blue |
||
Human Drosha Double Stranded RNA Specific Endoribonuclease (Drosha) ELISA Kit |
|||
| MBS167628-48StripWells | MyBiosource | 48-Strip-Wells | EUR 285 |
Human Drosha Double Stranded RNA Specific Endoribonuclease (Drosha) ELISA Kit |
|||
| MBS167628-5x96StripWells | MyBiosource | 5x96-Strip-Wells | EUR 1750 |
Human Drosha Double Stranded RNA Specific Endoribonuclease (Drosha) ELISA Kit |
|||
| MBS167628-96StripWells | MyBiosource | 96-Strip-Wells | EUR 425 |
SARS-CoV-2 (COVID-19) P681H Mutant Specific Spike Antibody [1G8D11] |
|||
| MBS154754-01mg | MyBiosource | 0.1mg | EUR 500 |
SARS-CoV-2 (COVID-19) P681H Mutant Specific Spike Antibody [1G8D11] |
|||
| MBS154754-5x01mg | MyBiosource | 5x0.1mg | EUR 2230 |
SARS-CoV-2 (COVID-19) P681H Mutant Specific Spike Antibody [7A4D12] |
|||
| MBS154755-01mg | MyBiosource | 0.1mg | EUR 500 |
SARS-CoV-2 (COVID-19) P681H Mutant Specific Spike Antibody [7A4D12] |
|||
| MBS154755-5x01mg | MyBiosource | 5x0.1mg | EUR 2230 |
SARS-CoV-2 (COVID-19) P681H Mutant Specific Spike Antibody [7C11H11] |
|||
| MBS154756-01mg | MyBiosource | 0.1mg | EUR 500 |
SARS-CoV-2 (COVID-19) P681H Mutant Specific Spike Antibody [7C11H11] |
|||
| MBS154756-5x01mg | MyBiosource | 5x0.1mg | EUR 2230 |
SARS-CoV-2 Spike Trimer (BA.1) Specific ELISA Kit (High Sensitivity) |
|||
| RAS-A111 | ACROBIOSYSTEMS | 96tests | EUR 845.3 |
|
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike protein is urgently needed to accelerate the development of COVID-19 vaccines. |
|||
SARS-CoV-2 Spike S1 (B.1.1.529) Specific ELISA Kit (For Vaccine Development) |
|||
| RAS-A170 | ACROBIOSYSTEMS | 96tests | EUR 845.3 |
|
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike S1 is urgently needed to accelerate the development of COVID-19 vaccines. |
|||
Human Drosha Double Stranded RNA Specific Endoribonuclease, Drosha GENLISA ELISA |
|||
| KBH4291 | Krishgen | 1 x 96 wells | EUR 286 |
SARS-CoV-2 Spike RBD (B.1.1.529) Specific ELISA Kit (For Vaccine Development) |
|||
| RAS-A082 | ACROBIOSYSTEMS | 96tests | EUR 845.3 |
|
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike protein is urgently needed to accelerate the development of COVID-19 vaccines. |
|||
SARS-CoV-2 Spike RBD (B.1.617.2) Specific ELISA Kit (For Vaccine Development) |
|||
| RAS-A092 | ACROBIOSYSTEMS | 96tests | EUR 845.3 |
|
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike protein is urgently needed to accelerate the development of COVID-19 vaccines. |
|||
SARS-CoV-2 Spike Trimer (B.1.617.2) Specific ELISA Kit (For Vaccine Development) |
|||
| RAS-A055 | ACROBIOSYSTEMS | 96tests | EUR 845.3 |
|
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike protein is urgently needed to accelerate the development of COVID-19 vaccines. |
|||
SARS-CoV-2 Spike Trimer (B.1.1.529) Specific ELISA Kit (For Vaccine Development) |
|||
| RAS-A081 | ACROBIOSYSTEMS | 96tests | EUR 845.3 |
|
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike protein is urgently needed to accelerate the development of COVID-19 vaccines. |
|||
SARS-CoV-2 Spike Trimer (BA.4) Specific ELISA Kit (For Vaccine Development) |
|||
| RAS-A124 | ACROBIOSYSTEMS | 96tests | EUR 845.3 |
|
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike protein is urgently needed to accelerate the development of COVID-19 vaccines. |
|||